Not medical advice. This website is not medical advice, a diagnosis, a match to a trial, or a recommendation to join a study. Listings are plain-English rewrites of public ClinicalTrials.gov records. Whether a site is still enrolling, and whether you qualify, can only be confirmed by the study team and your clinician. Source registry: ClinicalTrials.gov. Editorial rules: methodology.
PlainTrials
RecruitingNot a traditional drug phaseinterventionalRules rewrite

Not a traditional drug phase: Development of a screening algorithm designed to determine a "dysmobility" profile in patients with chronic illness. for Joint Osteoarthritis

Chronic illness is a public health issue and mobility loss is frequent in this population. Among its' multiple physical and psychological consequences, increased mortality and cardiovascular morbidity seem the main concern.

Official registry: https://clinicaltrials.gov/study/NCT04375280 · University Hospital, Clermont-Ferrand · enrollment listed as 5,000

What this phase means

This study does not use the classic phase 1–4 drug ladder. It may be a device, a behavior program, a surgery timing study, or an early feasibility test.

Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.

What the registry says happens

If you join, the listed intervention(s) are Development of a screening algorithm designed to determine a "dysmobility" profile in patients with chronic illness.. The registry lists allocation as na. Chronic illness is a public health issue and mobility loss is frequent in this population.

They plan to enroll about 5,000 people at Clermont-Ferrand. Taking part typically means study visits and measurements plus check-ins.

Official title (unrewritten)

Evaluation of Impaired Mobility in Chronic Illness Constitution of a Cohort

Interventions: Development of a screening algorithm designed to determine a "dysmobility" profile in patients with chronic illness.

Primary outcome (registry wording): dismobility score calculated from the results reported in secondary outcomes

Who it is for (from inclusion criteria)

  • Ages 18 Years to 90 Years
  • Man or woman aged 18 to 90
  • Patients with chronic pathology contributing to impaired mobility
  • Volunteers who have given their written consent
  • Affiliated to French health care system (for France)

Public study contact (from the registry)

Lise Laclautre

334.73.754.963

promo_interne_drci@chu-clermontferrand.fr

Published on ClinicalTrials.gov. Contact them as a possible participant. They decide eligibility.

Sites listed on ClinicalTrials.gov

1 listed

Related recruiting trials in this snapshot

RecruitingNot a traditional drug phaseBethesda, Maryland
Not a traditional drug phase: Medtronic Activa Tremor Control System for Parkinson's Disease

Background: \- Deep brain stimulation (DBS) is an approved surgery for certain movement disorders, like Parkinson's disease, that do not respond well to other treatments. DBS uses a battery-powered device called a neurostimulator (like a pacemaker) that is placed under the skin in the chest.

NCT01581580 · Official ClinicalTrials.gov record · National Institute of Neurological Disorders and Stroke (NINDS)

FAQ about this NCT record

Is NCT04375280 still recruiting?

The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.

What phase is NCT04375280?

Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.

Can PlainTrials tell me if I qualify for NCT04375280?

No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.

How to read a ClinicalTrials.gov record · Questions to ask the coordinator · Glossary